Aytu Biopharma, Inc.盘中异动早盘大幅跳水8.31%

市场透视11-14

北京时间2024年11月14日22时38分，Aytu Biopharma, Inc.（AYTU.us）股票出现异动，股价大幅下挫8.31%。截至发稿，该股报1.60美元/股，成交量3.8182万股，换手率0.62%，振幅5.54%。最近的财报数据显示，该股实现营业收入81.00百万美元，净利润-15.84百万美元，每股收益-2.86美元，毛利49.37百万美元，市盈率-0.58倍。机构评级方面，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2483885323?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-14 22:38","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2483885323","market":"us","top_or_hot":-1,"title":"Aytu Biopharma, Inc.盘中异动 早盘大幅跳水8.31%","media":"市场透视","content":"<div>\n<p>北京时间2024年11月14日22时38分，Aytu Biopharma, Inc.（AYTU.us）股票出现异动，股价大幅下挫8.31%。截至发稿，该股报1.60美元/股，成交量3.8182万股，换手率0.62%，振幅5.54%。最近的财报数据显示，该股实现营业收入81.00百万美元，净利润-15.84百万美元，每股收益-2.86美元，毛利49.37百万美元，市盈率-0.58倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422385898e42a51&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aytu Biopharma, Inc.盘中异动 早盘大幅跳水8.31%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAytu Biopharma, Inc.盘中异动 早盘大幅跳水8.31%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-14 22:38 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422385898e42a51&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年11月14日22时38分，Aytu Biopharma, Inc.（AYTU.us）股票出现异动，股价大幅下挫8.31%。截至发稿，该股报1.60美元/股，成交量3.8182万股，换手率0.62%，振幅5.54%。最近的财报数据显示，该股实现营业收入81.00百万美元，净利润-15.84百万美元，每股收益-2.86美元，毛利49.37百万美元，市盈率-0.58倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422385898e42a51&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422385898e42a51&s=b","article_id":"2483885323","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422385898e42a51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2483885323","pubTimestamp":1731595138,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年11月14日22时38分，Aytu Biopharma, Inc.股票出现异动，股价大幅下挫8.31%。Aytu Biopharma, Inc.股票所在的制药行业中，整体跌幅为0.46%。其相关个股中，Cyclo Therapeutics Inc C/Wts 11/12/2025、Sonoma Pharmaceuticals, Inc.、Flora Growth Corp.涨幅较大，Biofrontera Inc.、Akanda Corp.、Harrow, Inc.较为活跃，换手率分别为2.80%、1.63%、1.30%，振幅较大的相关个股有Im Cannabis Corp.、Durect Corporation、Talphera, Inc.，振幅分别为19.97%、11.69%、11.01%。Aytu Biopharma, Inc.公司简介：Aytu BioPharma Inc 是一家专业制药公司，拥有处方疗法和消费者健康产品的商业组合。AR101/enzastaurin 已获得 FDA 的孤儿药资格认定。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","AYTU":"Aytu BioScience, Inc."},"translate_title":"Intraday changes in Aytu Biopharma, Inc. plunged 8.31% in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AYTU":0.9},"content_text":"北京时间2024年11月14日22时38分，Aytu Biopharma, Inc.（AYTU.us）股票出现异动，股价大幅下挫8.31%。截至发稿，该股报1.60美元/股，成交量3.8182万股，换手率0.62%，振幅5.54%。最近的财报数据显示，该股实现营业收入81.00百万美元，净利润-15.84百万美元，每股收益-2.86美元，毛利49.37百万美元，市盈率-0.58倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Aytu Biopharma, Inc.股票所在的制药行业中，整体跌幅为0.46%。其相关个股中，Cyclo Therapeutics Inc C/Wts 11/12/2025(To Pur Com)、Sonoma Pharmaceuticals, Inc.、Flora Growth Corp.涨幅较大，Biofrontera Inc.、Akanda Corp.、Harrow, Inc.较为活跃，换手率分别为2.80%、1.63%、1.30%，振幅较大的相关个股有Im Cannabis Corp.、Durect Corporation、Talphera, Inc.，振幅分别为19.97%、11.69%、11.01%。Aytu Biopharma, Inc.公司简介：Aytu BioPharma Inc 是一家专业制药公司，拥有处方疗法和消费者健康产品的商业组合。 该公司的主要处方产品治疗注意力缺陷多动障碍和其他常见儿科疾病。 它正在建立一个互补的治疗开发管道，包括针对血管性埃勒斯-当洛斯综合征的前瞻性治疗（AR101/enzastaurin），这是一种罕见的遗传性疾病，导致高发病率和显着缩短的寿命。 AR101/enzastaurin 已获得 FDA 的孤儿药资格认定。 该公司经营两个部门：处方药部门（由处方药品组成的）和消费者健康部门，其中处方药部门的收入最大。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483885323"}

Aytu Biopharma, Inc.盘中异动 早盘大幅跳水8.31%

精彩评论

Aytu Biopharma, Inc.盘中异动早盘大幅跳水8.31%